Hematologic Neoplasms
📧 Sign up to get email alerts when something new happens for Hematologic Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Multi-center Investigation of Family Health.
Odense University Hospital is sponsoring a multi-center study on family health that is currently recruiting, with focus conditions including…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study
Update on the CATCH study evaluating close assessment and testing for chronic graft-versus-host disease. The trial status is completed.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash [NA]
An update on a clinical trial evaluating a protective oral care protocol using peppermint oil mouthwash for patients with hematologic neopla…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation [NA]
This update notes that a clinical trial evaluating a peer support intervention for patients undergoing hematopoietic stem cell transplantati…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Increasing Knowledge and Interest in Cancer Clinical Trials [NA]
This is a recruiting clinical trial listing sponsored by Hayley Thompson, investigating hematologic neoplasms and malignant solid neoplasms.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Early Palliative Care and Hematological Cancer Patients [NA]
A clinical trial evaluating early palliative care for patients with hematologic neoplasms was terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Therapeutic Education in Physical Activity (ETAF) [NA]
A clinical trial evaluating Therapeutic Education in Physical Activity (ETAF) for hematologic neoplasms has completed.
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation [NA]
This document reports that the NCT04691284 trial on the microbiome in cancer patients undergoing high-dose chemotherapy with stem cell trans…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital
A completed clinical trial at Haukeland University Hospital evaluated hypoxic red blood cells for burns and hematologic neoplasms; results h…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant [Phase 3]
A Phase 3 trial evaluated a self-management program and survivorship care plan to improve health outcomes for cancer survivors after stem ce…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
This clinical trial update reports completion of a UNC Lineberger Comprehensive Cancer Center study to establish the validity of a Best-Wors…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Evaluation of ClearLLab LS Screening Panel
Beckman Coulter completed a clinical trial evaluating the ClearLLab LS Screening Panel for hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System [Phase 1, Phase 2]
Takeda's TAK-981 was studied in Phase 1/2 trials for advanced solid tumors and hematologic malignancies, but the study was terminated with r…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer Patients [NA]
The clinical trial evaluating a multicomponent physical activity intervention to reduce psychosocial distress in cancer patients was termina…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation [Phase 2]
Phase 2 trial comparing cyclophosphamide plus abatacept with standard of care after allogeneic stem cell transplantation for graft-versus-ho…
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy
The trial investigating immunological, neurocognitive, activity, and driving fitness outcomes in CAR-T cell therapy for hematologic neoplasm…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating CMC-544 with allogeneic transplantation for CD22-positive lymphoid malignancies has completed, with results poste…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms
A ClinicalTrials.gov entry describes The Endothelial Cell Dysfunction and Outcome Project for Hematological Neoplasms, a recruiting study le…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors [Phase 2]
Phase 2 clinical trial update on hematopoietic cell transplantation for hematologic malignancies using related, HLA-haploidentical donors.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies [Phase 1, Phase 2]
A Phase 1/2 study evaluated safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of combining ibrutinib with nivolumab in pa…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies [Phase 1, Phase 2]
A Phase 1/2 study evaluating safety, tolerability, and efficacy of relatlimab in relapsed or refractory B-cell malignancies has completed wi…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients [Phase 3]
Phase 3 trial evaluating allogeneic hematopoietic stem cell transplantation from haplotype-mismatched related donors or unrelated donors in …
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating umbilical cord–derived mesenchymal stem cells for treatment-induced myelosuppression in hematologic mali…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers [Phase 2]
Phase 2 clinical trial evaluating a modified stem cell transplant procedure for hematologic neoplasms, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation [Phase 1, Phase 2]
Clinical trial update for Enasidenib (AG-221) in adults with advanced IDH2-mutant hematologic malignancies; Phase 1/2 study completed with r…